Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma.
El-Abtah ME, Talati P, Fu M, Chun B, Clark P, Peters A, Ranasinghe A, He J, Rapalino O, Batchelor TT, Gilberto Gonzalez R, Curry WT, Dietrich J, Gerstner ER, Ratai EM. El-Abtah ME, et al. Among authors: fu m. Neurooncol Adv. 2022 Aug 15;4(1):vdac128. doi: 10.1093/noajnl/vdac128. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36071927 Free PMC article.
Myo-Inositol Levels Measured with MR Spectroscopy Can Help Predict Failure of Antiangiogenic Treatment in Recurrent Glioblastoma.
El-Abtah ME, Wenke MR, Talati P, Fu M, Kim D, Weerasekera A, He J, Vaynrub A, Vangel M, Rapalino O, Andronesi O, Arrillaga-Romany I, Forst DA, Yen YF, Rosen B, Batchelor TT, Gonzalez RG, Dietrich J, Gerstner ER, Ratai EM. El-Abtah ME, et al. Among authors: fu m. Radiology. 2022 Feb;302(2):410-418. doi: 10.1148/radiol.2021210826. Epub 2021 Nov 9. Radiology. 2022. PMID: 34751617 Free PMC article.
MR spectroscopic imaging predicts early response to anti-angiogenic therapy in recurrent glioblastoma.
Talati P, El-Abtah M, Kim D, Dietrich J, Fu M, Wenke M, He J, Natheir SN, Vangel M, Rapalino O, Vaynrub A, Arrillaga-Romany I, Forst DA, Yen YF, Andronesi O, Kalpathy-Cramer J, Rosen B, Batchelor TT, Gonzalez RG, Gerstner ER, Ratai EM. Talati P, et al. Among authors: fu m. Neurooncol Adv. 2021 Apr 15;3(1):vdab060. doi: 10.1093/noajnl/vdab060. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34131648 Free PMC article.
Epidemiologic features and therapeutic strategies of kerion: A nationwide multicentre study.
Deng R, Chen X, Zheng D, Xiao Y, Dong B, Cao C, Ma L, Tong Z, Zhu M, Liu Z, Lu S, Fu M, Jin Y, Yin B, Li F, Li X, Abliz P, Liu H, Zhang Y, Yu N, Wu W, Xiong X, Zeng J, Huang H, Jiang Y, Chen G, Pan W, Sang H, Wang Y, Guo Y, Shi D, Yang J, Ran Y, Hu J, Yang L, Bai S, Yu J, Wang X, Li R. Deng R, et al. Among authors: fu m. Mycoses. 2024 Jun;67(6):e13751. doi: 10.1111/myc.13751. Mycoses. 2024. PMID: 38825584
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.
Petrie MC, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Shah SJ, Verma S, Jensen TJ, Einfeldt MN, Liisberg K, Perna E, Sharma K, Ezekowitz JA, Fu M, Melenovský V, Ito H, Lelonek M, Kosiborod MN; STEP-HFpEF Trial Committees and Investigators. Petrie MC, et al. Among authors: fu m. J Am Coll Cardiol. 2024 May 13:S0735-1097(24)07020-7. doi: 10.1016/j.jacc.2024.04.022. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 38819334 Free article.
4,439 results